Fig 1: Trehalose promoted the translocation of ATG9A from the ER to lysosomes. HaCaT cells were treated with or without 100 mM trehalose for 24 hours. Representative pictures of western blot showing expression levels of ATG3, ATG5, ATG7, and ATG9A in mitochondria (a), nucleus (b), ER (c), and cytoplasm (a, b). COX IV, IRE1α, histone H3, or GAPDH, served as loading controls. The statistical differences of ATG7 and ATG9A levels in the ER were calculated between cells treated with and without trehalose (c). Representative images of IF staining showing the localization of ATGs in mitochondria (ATG3, ATG5, ATG7, and ATG9A) (d), ER (ATG3, ATG5, ATG7, and ATG9A) (e) and lysosomes (ATG3, ATG5, ATG7, ATG9A, and LC3A/B) (f). (g) Representative images of IF staining showing the colocalization of ATG9A and LC3A/B. Scale bar, 20 μm. Enlarged images of colocolization positive cells were included. The statistical differences of Pearson's R value representing the localization of ATG9A in ER, ATG9A in lysosome and LC3A/B in lysosome, and the colocolization of ATG9A and LC3A/B was calculated between cells treated with and without trehalose. ∗∗∗P ≤ 0.001, ∗∗P ≤ 0.01, and ∗P ≤ 0.05. Con: control; TRE: trehalose.
Fig 2: ATG3 protein is a target of LC3/GABARAP conjugation and ATG4-mediated deconjugation. A, enrichment of transiently expressed 3xFLAG–LC3B G120 from HeLa control and ATG4B KO cells by IP with anti-FLAG antibody prior to Western blotting with anti-FLAG antibody (left) and anti-ATG3 antibodies (middle, right panel). Cells were transfected with GFP as a negative control. B, 3xFLAG–LC3B G120 expressed in HeLa ATG4B KO cells was enriched by IP with anti-FLAG antibody prior to treatment with 0.02 mg/ml recombinant GST–ATG4B WT or C74S at 37 °C for 1 h and Western blotting using anti-FLAG and anti-ATG3 N-ter antibody. C, HeLa control and ATG4B KO cells were transfected with 3xFLAG–LC3B G120, 3xFLAG–LC3B Q116P G120, or GFP as a negative control prior to harvesting. Western blotting was performed to detect 3xFLAG–LC3B and ATG3 using the same lysates diluted with either nonreducing (β-mercaptoethanol excluded) or reducing (standard recipe) sample buffer. Thioester-linked species are detected under nonreducing conditions only. D, Western blotting of HeLa ATG4B KO GFP–LC3B G120 cells transiently transfected with 3xFLAG–ATG3 WT and point mutant constructs. Samples were lysed in buffer lacking NEM and processed under reducing conditions (upper panel). The same constructs were used to rescue HeLa ATG3 KO cells treated for 3 h with 250 nm Torin1 and 10 nm baf A1 and assessed by Western blotting under nonreducing conditions (lower panel). E, schematic of human ATG4 protease cellular function in protein deconjugation (deLC3ylation), which counteracts covalent attachment of LC3/GABARAP (LC3ylation) to ATG3 protein at residue Lys-243.
Fig 3: Recruitment of autophagy machinery, including LC3B homologs, to stalled AVs is not sufficient to rescue the biogenesis defect.(A–E) Representative maximal projection micrographs of the distal neurites of fixed DRG neurons from aged mice. Stalled AVs are identified by colocalization of anti-ATG5 (green) and anti-ATG9 (blue). Antibodies to other autophagy components are visualized in red: ATG13 (A) or elongation complex components ATG12 (B), ATG7 (C), ATG16L1 (D), and ATG3 (E). Arrowheads denote colocalization state of AVs (stalled, filled arrowheads). Borders of magnifications of indicated puncta denote channel or colocalization state in merge. (F–I) Time series (channels merged) of Halo-ATG5, mAtg8s (mCh-GABARAP in F, mCh-GABARAPL2/GATE16 in G, mCh-GABARAPL1/GEC1 in H, and mScarlet-LC3A in I), and GFP-LC3B in the distal neurite of DRG neurons from aged mice depicting stalled AVs. Arrowheads denote colocalization of mAtg8s with stalled AVs. Magnified views of denoted puncta are shown below full micrograph; border color represents channel or colocalization state in merge. Time is indicated as time since stalled AV was first visible. (J) Quantification of the fraction of stalled AVs co-recruiting each LC3/GABARAP family member when individually overexpressed in DRGs from aged mice (mean ± SEM; n = 10 stalled AVs in three biological replicates for each mAtg8). ***p<0.001; ****p<0.0001 by two-tailed Fisher’s exact test. Scale bars, 2 µm.
Fig 4: The possible mechanism of YNJ-medicated serum on the regulation of autophagy in INS-1 cells. 1: treatment of INS-1 cells cultured under HG/HF conditions with YNJ-medicated serum. 2: there were some damaged organelles and proteins in INS-1 cells. 3: damaged organelles or proteins binding to p62. 4: p62 binding to LC3/GABARAP with the involvement of ATG3 \ATG7. 5: LC3 binding to PE to form LC3-II;. 6: LC3-II; and ATG2-WIPI2 were localized in PAS. 7: with the extension of the membrane, autophagosomes were formed. 8: autophagosomes fused with lysosomes to form autolysosomes where the sequestered contents were degraded. 9: After the clearance of damaged substances, INS-1 cells were protected from HG/HF-induced apoptosis by YNJ-medicated serum.
Fig 5: Angelicin promoted autophagy in cervical cancer cells. (A) Immunofluorescence micrographs demonstrating LC3B staining (green) and nucleus staining (blue) following gangelicin treatment (27.8 µM for HeLa, 36.6 µM for SiHa). (B) Western blot analysis detected angelicin-induced LC3B expression in HeLa and SiHa cells. To inhibit the degradation of LC3B-II, cells were pre-treated with 5 µM chloroquine for 6 h. (C) Western blot analysis of Atg3, Atg7 and Atg12-Atg5 protein expression in both HeLa and SiHa cells. LC3B, microtubule associated protein 1 light chain 3-β; Atg, autophagy related proteins.
Supplier Page from Abcam for Anti-ATG3 antibody [EPR4801]